Wrapping up #ASCO25, we thank everyone that visited our booth and attended the presentations on:
ASTRUM-005, a large, international phase 3 clinical trial analyzing Serplulimab versus placebo plus chemotherapy for ES-SCLC: https://lnkd.in/eKkxRvv4
An international phase III trial-in-progress comparing HLX22 in combination with trastuzumab and chemotherapy versus trastuzumab and chemotherapy with or without pembrolizumab for G/GEJC: https://lnkd.in/ehdxx5jz
Please visit https://lnkd.in/eejcPPmn for more information on ES-SCLC and to get connected.
Treatments under investigation; not FDA approved for use in the U.S. #ASCO25 #GoHenlius #SCLC #FOSUNPHARMAUSA
Please contact Nadra Belamri
nadra.belamri@fosunpharmausa.com for more info about Fosun Pharma USA
